Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tafluprost (Preservative-free vs Preservative-containing) in Glaucoma
NCT03104621Phase 4Completed
- Sponsor
- Gangnam Severance Hospital
- Start
- Mar 2013
- Primary completion
- Sep 2014
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, randomised, open-label trial of tafluprost in Primary Open Angle Glaucoma (POAG) and Normal tension glaucoma (NTG), sponsored by Gangnam Severance Hospital. Started Mar 2013; status: completed.
02
Drugs
tafluprost
03
Conditions
Primary Open Angle Glaucoma (POAG)Normal tension glaucoma (NTG)
Beyond the preview
Go deeper on NCT03104621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03104621.